Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    (1'R,6R,6aR,7R,13S,14S,16R)-6',8,14-Trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro(6,16-(epithiopropanooxymethano)-7,13-imino-6aH-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-20,1'(2&

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 18,282,028Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Blake Cassels & Graydon LLP

    02 2Gowling WLG

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Gowling WLG

    Trabectedin
    arrow
    American Pharma Summit
    Not Confirmed

    Gowling WLG

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Patent Expiration Date : 2025-10-26

    Date Granted : 2010-09-07

    Trabectedin

    Brand Name : YONDELIS

    Patent Number : 2582452

    Filing Date : 2005-10-26

    Strength per Unit : 1 mg / vial

    Dosage Form : Powder for solution

    Human Or VET : Human

    Route of Administration : Intravenous

    Patent Expiration Date : 2025-10-26

    Date Granted : 2010-09-07

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Blake Cassels & Graydon LLP

    Trabectedin
    arrow
    American Pharma Summit
    Not Confirmed

    Blake Cassels & Graydon LLP

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Patent Expiration Date : 2021-11-06

    Date Granted : 2009-10-13

    Trabectedin

    Brand Name : YONDELIS

    Patent Number : 2428160

    Filing Date : 2001-11-06

    Strength per Unit : 1 mg / vial

    Dosage Form : Powder for solution

    Human Or VET : Human

    Route of Administration : Intravenous

    Patent Expiration Date : 2021-11-06

    Date Granted : 2009-10-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Gowling WLG

    Trabectedin
    arrow
    American Pharma Summit
    Not Confirmed

    Gowling WLG

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Patent Expiration Date : 2025-10-27

    Date Granted : 2009-03-24

    Trabectedin

    Brand Name : YONDELIS

    Patent Number : 2520979

    Filing Date : 2005-10-27

    Strength per Unit : 1 mg / vial

    Dosage Form : Powder for solution

    Human Or VET : Human

    Route of Administration : Intravenous

    Patent Expiration Date : 2025-10-27

    Date Granted : 2009-03-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Blake Cassels & Graydon LLP

    Trabectedin
    arrow
    American Pharma Summit
    Not Confirmed

    Blake Cassels & Graydon LLP

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Patent Expiration Date : 2020-05-15

    Date Granted : 2005-10-11

    Trabectedin

    Brand Name : YONDELIS

    Patent Number : 2373794

    Filing Date : 2000-05-15

    Strength per Unit : 1 mg / vial

    Dosage Form : Powder for solution

    Human Or VET : Human

    Route of Administration : Intravenous

    Patent Expiration Date : 2020-05-15

    Date Granted : 2005-10-11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF